-
Medigene AG announces closing of its first SEPA tranche
03 Feb 2025 17:00 GMT
… , February 3, 2025. Medigene AG (Medigene or the “Company”, FSE … press release --- About Medigene AG Medigene AG (FSE: MDG1) … actual results achieved by Medigene may differ significantly from … these forward-looking statements. Medigene® is a registered …
-
Medigene announces KRAS G12V as first target for TCR─guided T cell engagers
10 Dec 2024 12:12 GMT
… for the partnership between Medigene and WuXi Biologics, which … collaboration seeks to harness Medigene’s expertise in the … End-To-End Platform, Medigene discovers natural TCR sequences … and other challenging neoantigens.
Medigene AG is an immuno-oncology …
-
Medigene AG Announces KRAS G12V as First Target for TCR-guided T Cell Engagers
09 Dec 2024 10:00 GMT
… , December 9, 2024. Medigene AG (Medigene or the “Company”, FSE … collaboration seeks to harness Medigene’s expertise in the … press release --- About Medigene AG Medigene AG (FSE: MDG1) … these forward-looking statements. Medigene® is a registered trademark …
-
KRAS G12V is target for Medigene, Wuxi TCR-TCE collaboration
09 Dec 2024 18:52 GMT
-
Medigene Receives Milestone Payment from Regeneron Pharmaceuticals, Inc.
03 Dec 2024 11:07 GMT
… , December 3, 2024. Medigene AG (Medigene or the “Company”, FSE … press release ---
About Medigene AG
Medigene AG (FSE: MDG1) … actual results achieved by Medigene may differ significantly from … these forward-looking statements. Medigene® is a registered trademark …
-
Medigene Receives Milestone Payment from Regeneron Pharmaceuticals, Inc.
03 Dec 2024 10:00 GMT
… , December 3, 2024. Medigene AG (Medigene or the “Company”, FSE … press release --- About Medigene AG
Medigene AG (FSE: MDG1) … actual results achieved by Medigene may differ significantly from … these forward-looking statements. Medigene® is a registered trademark …
-
Medigene axes staff and refocuses its TCR pipeline
26 Nov 2024 15:51 GMT
… pipeline.
In a statement, Medigene's chief executive, … came in September and Medigene had been intending to … potential of MDG1015.
"Medigene has continuously prioritised projects and … process," he added.
Medigene ended the third quarter with …
-
Medigene AG Announces Refocus of Corporate Strategy and Organizational Realignment
26 Nov 2024 13:00 GMT
… , November 26, 2024. Medigene AG (Medigene, FSE: MDG1, Prime … will remain unaffected. “Medigene has continuously prioritized projects … this difficult process.” Medigene remains confident in the … release --- About Medigene AG Medigene AG (FSE: MDG1 …
-
Medigene Presents Data On An Innovative IFN-Γ Biosensor Technology At SITC 2024
12 Nov 2024 12:51 GMT
… Martinsried, November 12, 2024. Medigene AG (Medigene or the“Company”, FSE: … optimization technology to the Medigene End-to-End Platform … press release --- About Medigene AG Medigene AG (FSE: MDG1) … and durability of response. Medigene's MDG1015 received …
-
Medigene Presents Data on an Innovative IFN-γ Biosensor Technology at SITC 2024
12 Nov 2024 12:00 GMT
… Martinsried, November 12, 2024. Medigene AG (Medigene or the “Company”, FSE … optimization technology to the Medigene End-to-End Platform … press release --- About Medigene AG Medigene AG (FSE: MDG1) … and durability of response. Medigene’s MDG1015 received IND …
About
© 1995-2025